Pathological and Epidemiological Factors Associated with Advanced Stage at Diagnosis of Breast Cancer

Overview

Journal Br Med Bull

Publisher Oxford University Press

Specialty General Medicine

Date 2012 Aug 7

PMID 22864058

Citations 21

Authors

R Verma

R L Bowen

S E Slater

F Mihaimeed

J L Jones

Affiliations

Soon will be listed here.

Abstract

Background: Breast cancer is a highly heterogeneous disease, but the stage at presentation significantly influences outcome. It is important to dissect the pathobiological and epidemiological factors that influence the stage at presentation in order to develop effective strategies to improve clinical outcome.

Sources Of Data: PubMed references relating to breast cancer subtypes, molecular classification of breast cancer, genetic susceptibility, young women and breast cancer.

Areas Of Agreement: HER-2 positive, basal-like tumours and inflammatory breast cancers (IBC) more frequently present as late stage disease. Socioeconomic, cultural and ethnic background also influence stage at presentation.

Areas Of Controversy: The biology of IBC is poorly understood. Relative contribution of social and genetic factors in certain ethnic groups. GROWING POINTS Molecular determinants of breast cancer behaviour. Genetic and biological factors influencing disease phenotype in different ethnic groups.

Areas Timely For Developing Research: Biology of basal-like tumours and IBC. Role of predisposition of genetic variants in determining breast cancer phenotypes. Biological differences in breast cancer from different ethnic groups.

Citing Articles

Knockdown of CKAP2 Inhibits Proliferation, Migration, and Aggregate Formation in Aggressive Breast Cancer.

Dos Santos A, Ouellete G, Diorio C, Elowe S, Durocher F Cancers (Basel). 2022; 14(15).

PMID: 35954424 PMC: 9367390. DOI: 10.3390/cancers14153759.

Association Between Obesity and Clinicopathological Profile of Patients with Newly Diagnosed Non-Metastatic Breast Cancer in Saudi Arabia.

Alshamsan B, Suleman K, Agha N, Abdelgawad M, Alzahrani M, Elhassan T Int J Womens Health. 2022; 14:373-384.

PMID: 35309953 PMC: 8926012. DOI: 10.2147/IJWH.S343558.

Evaluating the effect of Alantolactone on the expression of N-cadherin and Vimentin genes effective in epithelial-mesenchymal transition (EMT) in breast cancer cell line (MDA-MB-231).

Naderi R, Gholizadeh-Ghaleh Aziz S, Haghigi-Asl A Ann Med Surg (Lond). 2022; 73:103240.

PMID: 35079373 PMC: 8767280. DOI: 10.1016/j.amsu.2021.103240.

Hsa_circRNA_102229 facilitates the progression of triple-negative breast cancer via regulating the miR-152-3p/PFTK1 pathway.

Du C, Zhang J, Zhang L, Zhang Y, Wang Y, Li J J Gene Med. 2021; 23(9):e3365.

PMID: 34031947 PMC: 8459279. DOI: 10.1002/jgm.3365.

Correlation of immune infiltration with clinical outcomes in breast cancer patients: The 25-gene prognostic signatures model.

Liu Y, Fu W, Chen W, Lin Y, Zhang J, Song C Cancer Med. 2021; 10(6):2112-2124.

PMID: 33626234 PMC: 7957182. DOI: 10.1002/cam4.3678.